Thyroid Hormone T3 Counteracts STZ Induced Diabetes in Mouse
2011

Thyroid Hormone T3 Counteracts STZ Induced Diabetes in Mice

Sample size: 25 publication 10 minutes Evidence: moderate

Author Information

Author(s): Verga Falzacappa Cecilia, Mangialardo Claudia, Madaro Luca, Ranieri Danilo, Lupoi Lorenzo, Stigliano Antonio, Torrisi Maria Rosaria, Bouchè Marina, Toscano Vincenzo, Misiti Silvia

Primary Institution: Dipartimento di Medicina Sperimentale, Sapienza Università di Roma, Roma, Italy

Hypothesis

The thyroid hormone T3 can preserve and protect functional β cell mass in STZ diabetic animals.

Conclusion

T3 acts as a protective factor against STZ induced diabetes by preserving β cell mass and function.

Supporting Evidence

  • T3 treatment preserved islet morphology and function in STZ-treated mice.
  • T3 administration significantly reduced apoptosis in β cells compared to STZ treatment alone.
  • T3 maintained insulin production levels comparable to control mice.
  • T3 activated the Akt signaling pathway, which is crucial for β cell survival.
  • STZ treatment alone resulted in significant β cell loss and dysfunction.

Takeaway

This study shows that a hormone called T3 can help protect mice from diabetes by keeping their insulin-producing cells healthy.

Methodology

Diabetes was induced in Balb/c male mice using low dose Streptozotocin injections, and T3 was administered to assess its protective effects on β cell mass and function.

Potential Biases

Potential bias in the selection of animal models and treatment protocols.

Limitations

The study was conducted on mice, and results may not directly translate to humans.

Participant Demographics

Six-weeks-old male Balb/c mice.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0019839

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication